204 related articles for article (PubMed ID: 31720743)
1. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
[TBL] [Abstract][Full Text] [Related]
2. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
[TBL] [Abstract][Full Text] [Related]
3. Glucokinase gene mutations (MODY 2) in Asian Indians.
Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
[TBL] [Abstract][Full Text] [Related]
4. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
[TBL] [Abstract][Full Text] [Related]
5. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
6. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of the glucokinase impaired function - GCK MODY today.
Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
[TBL] [Abstract][Full Text] [Related]
8. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
[TBL] [Abstract][Full Text] [Related]
10. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
[TBL] [Abstract][Full Text] [Related]
11. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
[TBL] [Abstract][Full Text] [Related]
12. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
[TBL] [Abstract][Full Text] [Related]
13. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
14. Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus.
Codner E; Rocha A; Deng L; Martínez-Aguayo A; Godoy C; Mericq V; Chung WK
Pediatr Diabetes; 2009 Sep; 10(6):382-8. PubMed ID: 19309449
[TBL] [Abstract][Full Text] [Related]
15. Identification of GCK-maturity-onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features.
Hughes AE; De Franco E; Globa E; Zelinska N; Hilgard D; Sifianou P; Hattersley AT; Flanagan SE
Pediatr Diabetes; 2021 Sep; 22(6):876-881. PubMed ID: 34085361
[TBL] [Abstract][Full Text] [Related]
16. Functional Inactivation of
Mascolo E; Liguori F; Stufera Mecarelli L; Amoroso N; Merigliano C; Amadio S; Volonté C; Contestabile R; Tramonti A; Vernì F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477627
[TBL] [Abstract][Full Text] [Related]
17. Glucokinase mutations in pediatric patients with impaired fasting glucose.
Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
[TBL] [Abstract][Full Text] [Related]
18. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
19. Two novel GCK mutations in Chinese patients with maturity-onset diabetes of the young.
Wang T; Zhu M; Wang Y; Hu C; Fang C; Hu J
Endocrine; 2024 Jan; 83(1):92-98. PubMed ID: 37847371
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous lys169Glu mutation of glucokinase gene in a Chinese family having glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Zhou W; Chen M; Zhou H; Zhang Z
J Postgrad Med; 2019; 65(4):241-243. PubMed ID: 31571622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
